Esta es un versión antigua publicada el 22-08-2022. Consulte la versión más reciente.

Carta el editor: Características de los pacientes con cáncer de pulmón de célula no pequeña en el Instituto Nacional de Cancerología de Colombia

Autores/as

  • Andrés Felipe Cardona Grupo Oncología Clínica y Traslacional, Clínica del Country, Bogotá, Colombia Fundación para la Investigación Clínica y Molecular Aplicada del Cáncer – FICMAC, Bogotá, Colombia Grupo de Investigación en Oncología Molecular y Sistemas Biológicos, (Fox-G), Universidad El Bosque, Bogotá, Colombia https://orcid.org/0000-0001-8345-0944
  • Oscar Arrieta-Mercado Unidad Oncología Torácica y Laboratorio de Oncología Personalizada, Instituto Nacional de Cancerología – INCan, Ciudad de México, México https://orcid.org/0000-0002-1164-3779
  • Alejandro Ruíz-Patiño Fundación para la Investigación Clínica y Molecular Aplicada del Cáncer – FICMAC, Bogotá, Colombia Grupo de Investigación en Oncología Molecular y Sistemas Biológicos, (Fox-G), Universidad El Bosque, Bogotá, Colombia https://orcid.org/0000-0003-1274-9273
  • Leonardo Rojas Departamento Oncología Clínica, Clínica Colsanitas, Bogotá, Colombia Grupo de Investigación en Oncología Molecular y Sistemas Biológicos, (Fox-G), Universidad El Bosque, Bogotá, Colombia https://orcid.org/0000-0002-7865-5424
  • Christian Rolfo Centro de Oncología Torácica, Tisch Cáncer Center, Mount Sinai Hospital System & Icahn School of Medicine, Mount Sinai, New York, NY, USA https://orcid.org/0000-0002-5109-0267

DOI:

https://doi.org/10.35509/01239015.815

Referencias bibliográficas

Alarcón ML, Bruges R, Carvajal C, Vallejo C, Beltrán R. Características de los pacientes con cáncer de pulmón de célula no pequeña en el Instituto Nacional de Cancerología de Colombia. Rev Colomb Cancerol. 2021;25(2):xx-xx. Disponible en internet: 01/12/2020 https://doi.org/10.35509/01239015.706

Zhou F, Zhou C. Lung cancer in never smokers—the East Asian experience. Transl Lung Cancer Res. 2018 Aug; 7(4): 450–463. https://doi.org/10.21037/tlcr.2018.05.14

Cho J, Choi SM, Lee J, et al. Proportion and clinical features of never-smokers with non-small cell lung cancer. Chin J Cancer. 2017 Feb 8; 36(1):20. https://doi.org/10.21037/tlcr.2018.05.14.

Kobrinsky NL, Klug MG, Hokanson PJ, Sjolander DE, Burd L. Impact of smoking on cancer stage at diagnosis. J Clin Oncol. 2003 Mar 1;21(5):907-13. https://doi.org/10.1200/JCO.2003.05.110.

Yano T, Miura N, Takenaka T, Haro A, Okazaki H, Ohba T et al. Never-smoking nonsmall cell lung cancer as a separate entity: clinicopathologic features and survi val. Cancer 2008;113:1012-8. https://doi.org/10.1002/cncr.23679

Kim CH, Lee YC, Hung RJ, McNallan SR, Cote ML, Lim W-Y et al. Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the International Lung Cancer Consortium (ILCCO). Int J Cancer. 2014 Oct 15; 135(8):1918-30. https://doi.org/ 10.1002/ijc.28835

Yu IT , Chiu YL, Au JS, Wong T-W , Tang J-L. Dose-response relationship between cooking fumes exposures and lung cancer among Chinese nonsmoking women. Cancer Res. 2006 May 1; 66(9):4961-7. https://doi.org/10.1158/0008-5472.CAN-05-2932

Wang TJ, Zhou BS, Shi JP . Lung cancer in nonsmoking Chinese women: a case-control study. Lung Cancer. 1996 Mar; 14 (Suppl 1):S93-8. https://doi.org/ 10.1016/s0169-5002(96)90214-7.

Wu PF , Lee CH, Wang MJ, Goggins WB, Chiang T-A, Huang M-S, et al. Cancer aggregation and complex segregation analysis of families with female non-smoking lung cancer probands in Taiwan. Eur J Cancer. 2004 Jan; 40(2):260-6. https://doi.org/10.1016/j.ejca.2003.08.021.

Jin YT , Xu YC, Yang RD, Huang CF , Xu CW, He XZ. Familial aggregation of lung cancer in a high incidence area in China. Br J Cancer. 2005 Apr 11; 92(7):1321-5. https://doi.org/10.1038/sj.bjc.6602465.

Zhang WP, Yang C, Xu LJ, Wan W , Song L , He X-F. Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on lung cancer risk: A meta-analysis and re-analysis of systematic meta-analyses. Medicine (Baltimore). 2021 Jul 2;100(26):e26104. https://doi.org/10.1097/MD.0000000000026104.

Cahuana Pinto RSM, Castro Panzenhagen A, Silva Oli veir a LF, Fonseca Moreira JC , Schnorr CE . Incidence of lung cancer and mortality among civ il construction industry workers: A protocol for a systematic review and meta-analysis. PLoS One. 2021 Apr 26;16(4):e0250377. https://doi.org/10.1371/journal.pone.0250377.

Fuentes N, Silva Rodriguez M, Silveyra P. Role of sex hormones in lung cancer. Exp Biol Med (Maywood). 2021 Jun 3:15353702211019697. https://doi.org/ 10.1177/15353702211019697.

Kachuri L, Johansson M, Rashkin SR, Graff RE , Bossé Y , Manem V et al. Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility . Nat Commun. 2020 Jan 7;11(1):27. https://doi.org/10.1038/s41467-019-13855-2.

Liang HY, Li XL, Yu XS, Guan P, Yin Z-H, He QC et al. tuberculosis and lung cancer risk: a systematic review. Int J Cancer. 2009 Dec 15;125(12):2936-44. https://doi.org/10.1002/ijc.24636. PMID: 19521963.

Tsyganov MM, Pevzner AM, Ibr agimova MK, Deryusheva IV , Litviakov NV. Human papillomavirus and lung cancer: an overview and a meta-analysis. J Cancer Res Clin Oncol. 2019 Aug;145(8):1919-1937. https://doi.org/10.1007/s00432-019-02960-w.

Sun Y, Ren Y, Fang Z, Li C, Fang R, Gao B et al. Lung adenocarcinoma from East Asian never-smokers is a dis ease J Clin Oncol. 2010 Oct 20; 28(30):4616-20. https://doi.org/10.1200/JCO.2010.29.6038

Ren S, Kuang P, Zheng L, Su C, Li J, Li B et al. Analysis of driver mutations in female non-smoker Asian patients with pulmonary adenocarcinoma. Cell Biochem Biophys. 2012 Nov; 64(2):155-60. https://doi.org/10.1007/s12013-012-9384-8

Ha SY, Choi SJ, Cho JH, Choi HJ , Lee J, Jung K et al. Lung cancer in never-smoker Asian females is driven by oncogenic mutations, most often involving EGFR. Oncotarget. 2015 Mar 10; 6(7):5465-74. https://doi.org/10.18632/oncotarget.2925

Hung RJ, Spitz MR, Houlst on RS, Schwartz AG, Fiel d JK, Ying J et al. Lung Cancer Ris k in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region. J Thorac Oncol. 2019 Aug;14(8):1360-1369. https://doi.org/10.1016/j.jtho.2019.04.008.

Gou LY, Niu FY, Wu YL, Zhong WZ. Differences in driver genes between smoking-related and non-smoking-related lung cancer in the Chinese population. Cancer. 2015 Sep 1; 121 Suppl 17():3069-79. https://doi.org/10.1002/cncr.29531.

Ruiz-Patiño A, Herrera E, Prieto JC, (2020). Interregional variation of Non-small cell lung cancer markers is associated with population substructures. Congreso Anual de la Asociación Colombiana de Hematología y Oncología – ACHO. Disponible en: https://acho.com.co/acho/revista-acho-2/

Arrieta O, Cardona AF, Bramuglia G, Cruz-Rico G, Corrales L, Martín C et al. On behalf of the CLICaP. Molecular Epidemiology of ALK Rearrangements in Advanced Lung Adenocarcinoma in Latin America. Oncology. 2019;96(4):207-216. https://doi.org/1159/000493733.

Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY , Cronin KA et al. The Effect of Advances in Lung-Cancer Treatment on Population Mortality. N Engl J Med. 2020 Aug 13;383(7):640-649. https://doi.org/ 10.1056/NEJMoa1916623.

Gelatti ACZ, Cordeiro de Lima VC, Freitas H, Werutsky G , Gaiger AM , Klock C et al. Real-World Prevalence of PD-L1 Expressi on Among Tumor Samples From Patients With Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2020 Nov;21(6):e511-e515. https://doi.org/10.1016/j.cllc.2020.04.007.

Velcheti V, Patwardhan PD, Liu FX, Chen X , Cao X, Burke T. Real-world PD-L1 testing and dis tribution of PD-L1 tumor expressi on by immunohis tochemistry assay type among patients with metastatic non-small cell lung cancer in the United States. PLoS One. 2018 Nov 8;13(11):e0206370. https://doi.org/10.1371/journal.pone.0206370.

Dietel M, Savelov N, Salanova R. Real-world prevalence of PD-L1 expressi on in locally advanced or metastatic non-small cell lung cancer (NSCLC): The global, multicentre EXPRESS study. J Thor Oncol. 2018;13(4 suppl):S 74-S75.

Di Maio M, Perrone F, Conte P. Real-World Evidence in Oncology: Opportunities and Limitations. Oncologist. 2020 May;25(5):e746-e752. https://doi.org/ 10.1634/theoncologist.2019-0647.

Kumar R, Castillero F, Bhandari S, Malapati S , Kloecker G. The Hispanic paradox in non-small cell lung cancer. Hematol Oncol Stem Cell Ther. 2021 Mar 10:S1658-3876(21)00029-7. https://doi.org/10.1016/j.hemonc.2021.02.004.

,RArenrohT,NnosrettaP,GerfahC-acoS,JgnahZ-torraCNag A, Watson J et al. Genetic Ancestry Contributes to Somatic Mutations in Lung Cancers from Admixed Latin American Populations. Cancer Discov. 2021 Mar;11(3):591-598. https://doi.org/10.1158/2159-8290.CD-20-1165.

Mascarenhas E, Gelatti AC, Araújo LH, Baldotto C, Mathias Brazilian non-small cell lung cancer patients (GBOT 0118/LACOG0418). Thorac Cancer. 2021 Mar;12(5):580-587. https://doi.org/0.1111/1759-7714.13777.

Cif uentes C, Lombana M, Vargas H, et al (2020). Application sequencing (NGS) assay to improve cancer care in a developing country. Congreso Anual de la Asociación Colombiana de Hematología y Oncología – ACHO. Disponible en: https://acho.com.co/acho/revista-acho-2

Cómo citar

[1]
Cardona, A. et al. 2022. Carta el editor: Características de los pacientes con cáncer de pulmón de célula no pequeña en el Instituto Nacional de Cancerología de Colombia. Revista Colombiana de Cancerología. 25, 4 (ago. 2022), 226–231. DOI:https://doi.org/10.35509/01239015.815.

Descargas

Los datos de descargas todavía no están disponibles.

Descargas

Publicado

14-12-2021 — Actualizado el 22-08-2022

Versiones

Número

Sección

Cartas al editor